Comprehensive cancer screening for early detection and prevention in women
The Cancer Screening Female Profile offered by Diagnostiki Athinon is a carefully designed laboratory screening test that includes key tumor markers used to evaluate cancer risk in women. It is intended for women who wish to proactively monitor their health, especially those with a personal or family history of malignancy.
Tumor markers are not diagnostic on their own. Still, they can be invaluable for early detection, monitoring high-risk individuals, or following up after cancer treatment—always in combination with clinical assessment and imaging.
Who should consider this panel?
This panel is ideal for:
- Women over 40 as part of their annual health check-up
- Women with a family history of breast, ovarian, colorectal, or pancreatic cancer
- Women with a history of benign tumors or abnormal screening results
- Individuals with unexplained symptoms such as persistent fatigue, weight loss, or gastrointestinal discomfort
What the Cancer Screening Female Profile includes
Blood-based tumor markers
- CA 125 – associated with ovarian, endometrial, and other gynecological cancers
- CA 15-3 – commonly used in breast cancer monitoring
- CEA (Carcinoembryonic Antigen) – linked to colorectal, gastric, and lung cancers
- CA 19-9 – used mainly in pancreatic and gastrointestinal cancers
- CA 72-4 – marker for gastric and gynecological tumors
- AFP (Alpha-Fetoprotein) – used in liver cancer and certain ovarian tumors
- NSE (Neuron-Specific Enolase) – associated with neuroendocrine tumors
- CYFRA 21-1 – useful in detecting non-small cell lung cancer and bladder cancer
Stool-based tumor markers
- M2-PK (Pyruvate Kinase type M2) – detects altered metabolic activity of colorectal cancer cells
- Fecal Occult Blood (FOB) – identifies hidden gastrointestinal bleeding, which may indicate colorectal cancer
When should it be done?
This panel is recommended once per year for preventive screening, and more frequently for high-risk individuals or those undergoing cancer surveillance after diagnosis or treatment.
Why choose the Cancer Screening Female Profile
The Cancer Screening Female Profile provides a robust cancer risk assessment and monitoring tool. Early detection of abnormal tumor marker levels can lead to faster diagnosis, better outcomes, and timely medical intervention. Performed with accuracy, discretion, and expert care at Athens Lab, it supports a proactive approach to women’s health.
Take control of your health. Book your Female Tumor Marker Panel today at Athens Lab and invest in your long-term well-being.
But beware! Tumor marker levels alone cannot prove malignancy. Clinical examination and possibly other laboratory tests are necessary.
